ABL2 Translocation/Rearrangement

The ABL2 Translocation/Rearrangement test is a specialized molecular or cytogenetic test used to detect translocations or rearrangements involving the ABL2 gene. Alterations in this gene have been identified in certain hematological malignancies and, less commonly, in some solid tumors. Detecting these genetic changes helps characterize the underlying disease, supports an accurate diagnosis, and may provide valuable information for prognosis and treatment planning. The test is typically performed as part of a comprehensive genetic evaluation in individuals with suspected or confirmed cancer.

Who should get this test done?

This test may be recommended for individuals who:

●     Have suspected or confirmed leukemia or other hematological malignancies requiring genetic evaluation.

●     Show clinical or laboratory findings suggestive of a gene rearrangement involving ABL2.

●     Require molecular testing to classify a cancer more precisely.

●     Need additional genetic investigations to support treatment planning.

●     Are advised by an oncologist or hematologist to undergo targeted genetic testing.

Why consider this test?

Cancer is often driven by specific genetic changes, and identifying these alterations can provide important insights into the disease. The ABL2 Translocation/Rearrangement test helps detect structural changes involving the ABL2 gene, allowing healthcare providers to better understand the biology of the cancer. The information obtained can support diagnosis, aid in disease classification, and contribute to personalized treatment decisions when interpreted alongside other clinical and laboratory findings.

More information

The ABL2 gene encodes a tyrosine kinase protein involved in cell growth, differentiation, and signaling. Rearrangements involving this gene can lead to abnormal cellular activity and have been associated with certain cancers. Depending on the clinical indication, the test may be performed using techniques such as Fluorescence In Situ Hybridization (FISH) or Next-Generation Sequencing (NGS). It is usually requested as part of a broader molecular profiling panel and is interpreted in conjunction with pathology findings, clinical history, and other genetic test results.

Other names of the test

●     ABL2 Gene Rearrangement Test

●     ABL2 Translocation Analysis

●     ABL2 Gene Fusion Test

●     ABL2 Rearrangement Detection

●     ABL2 Molecular Genetic Test